Pfizer Stock: A Golden Buying Opportunity (Rating Upgrade)

Now you can get access to the latest and highest-quality analysis of recent Wall Street buying and selling ideas with just one subscription to Beyond the Wall Investing ! There is a free trial and a special discount of 10% for you. Join us today!I reinitiated my coverage of Pfizer Inc. (NYSE: PFE ) (NEOE: PFE:CA ) stock at the end of December 2023 with a "Buy" rating, when the stock was trading at $27.86 apiece. Since then, I have published 4 more bullishDaniel Sereda is chief investment analyst at a family ...